ORIC Pharmaceuticals, Inc. (ORIC) Misses Q4 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. SPY
5. ANT
6. META
7. BA
8. INTC
9. JBLU
10. AAPL

Go back to ORIC Pharmaceuticals, Inc. (ORIC) Misses Q4 EPS by 1c

ORIC Pharamceuticals (ORIC) PT Raised to $17 at Oppenheimer, 'Executing On Multiple Fronts'

March 12, 2024 9:21 AM EDT

Oppenheimer analyst Matthew Biegler raised the price target on ORIC Pharamceuticals (NASDAQ: ORIC) to $17.00 (from $14.00) while maintaining a Outperform rating.

The analyst comments "Monday, ORIC reported 2023 financials. We are pleased with managements execution, adding in strategic financings on the heels of... More